157 related articles for article (PubMed ID: 20005370)
1. Nucleosome serum levels in acute hepatic failure and MARS treatment.
Roth GA; Lubsczyk BA; Pilz J; Faybik P; Hetz H; Krenn CG
Transplant Proc; 2009 Dec; 41(10):4207-10. PubMed ID: 20005370
[TBL] [Abstract][Full Text] [Related]
2. MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study.
Roth GA; Faybik P; Hetz H; Ankersmit HJ; Hoetzenecker K; Bacher A; Thalhammer T; Krenn CG
Scand J Gastroenterol; 2009; 44(6):745-51. PubMed ID: 19247846
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin-2 serum levels are increased in acute hepatic failure.
Roth GA; Nickl S; Lebherz-Eichinger D; Schmidt EM; Ankersmit HJ; Faybik P; Hetz H; Krenn CG
Transplant Proc; 2013; 45(1):241-4. PubMed ID: 23375308
[TBL] [Abstract][Full Text] [Related]
4. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
5. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.
Lin SD; Kawakami T; Ushio A; Sato A; Sato S; Iwai M; Endo R; Takikawa Y; Suzuki K
J Gastroenterol Hepatol; 2006 Feb; 21(2):374-80. PubMed ID: 16509861
[TBL] [Abstract][Full Text] [Related]
6. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.
Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
Transpl Int; 2008 Sep; 21(9):857-66. PubMed ID: 18510596
[TBL] [Abstract][Full Text] [Related]
7. [Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system].
Zhou X; Wang X; Yang Y; Zhao L; Miao J; Ding J; Fan D
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):213-5. PubMed ID: 12113683
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure.
Lebherz-Eichinger D; Schwarzer R; Motal MC; Klaus DA; Mangold A; Ankersmit HJ; Berlakovich GA; Krenn CG; Roth GA
Biochem Med (Zagreb); 2015; 25(2):252-61. PubMed ID: 26110038
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure.
Hessel FP; Bramlage P; Wasem J; Mitzner SR
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):213-20. PubMed ID: 19773666
[TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
Roth GA; Faybik P; Hetz H; Hacker S; Ankersmit HJ; Bacher A; Thalhammer T; Krenn CG
Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
[TBL] [Abstract][Full Text] [Related]
11. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
12. Comparison of long-term outcome of patients with Wilson's disease presenting with acute liver failure versus acute-on-chronic liver failure.
Thanapirom K; Treeprasertsuk S; Komolmit P; Tangkijvanich P; Kullavanijaya P
J Med Assoc Thai; 2013 Feb; 96(2):150-6. PubMed ID: 23936979
[TBL] [Abstract][Full Text] [Related]
13. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL
Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
[TBL] [Abstract][Full Text] [Related]
14. Gc-globulin in liver disease.
Schiødt FV
Dan Med Bull; 2008 Aug; 55(3):131-46. PubMed ID: 19232164
[TBL] [Abstract][Full Text] [Related]
15. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation.
Isoniemi H; Koivusalo AM; Repo H; Ilonen I; Höckerstedt K
Transplant Proc; 2005 Mar; 37(2):1088-90. PubMed ID: 15848631
[TBL] [Abstract][Full Text] [Related]
16. Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?
Koivusalo AM; Kantola T; Arola J; Höckerstedt K; Kairaluoma P; Isoniemi H
Ther Apher Dial; 2009 Oct; 13(5):413-8. PubMed ID: 19788458
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of efficacy and safety of using molecular adsorbent recirculating system in the treatment of patients with chronic liver failure].
Lu XB; Xiao L; Zhang YX; Liu H; Yan GX; Xu L; Sun LH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):44-6. PubMed ID: 17207365
[TBL] [Abstract][Full Text] [Related]
18. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.
Wasmuth HE; Kunz D; Yagmur E; Timmer-Stranghöner A; Vidacek D; Siewert E; Bach J; Geier A; Purucker EA; Gressner AM; Matern S; Lammert F
J Hepatol; 2005 Feb; 42(2):195-201. PubMed ID: 15664244
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy.
Saich R; Selden C; Rees M; Hodgson H
Artif Organs; 2007 Sep; 31(9):732-42. PubMed ID: 17725701
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.
Sen S; Davies NA; Mookerjee RP; Cheshire LM; Hodges SJ; Williams R; Jalan R
Liver Transpl; 2004 Sep; 10(9):1109-19. PubMed ID: 15350001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
